Carl Icahn Takes a 9.9% Stake in JBLU
Here’s The Hot Corner, with data through February 12, 2024:
In a Form 4 filing, director Farhad Nanji revealed an additional purchase of RXO Inc $RXO shares with a total value of $37.8 million.
Cathie Wood’s ARK Investment Management filed a 13G for Recursion Pharmaceuticals Inc $RXRX, increasing its ownership stake from 9.91% to 11.08%.
Stay tuned. We'll be back on Wednesday with more insider activity.
Sign up for The Hot Corner to have these insider transactions e-mailed to you every Monday through Friday.
And please reach out with any questions. We love hearing from you!
All Star Charts Team